PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.

[1]  C. Kushmerick,et al.  Characteristics of dorsal root ganglia neurons sensitive to Substance P , 2014, Molecular pain.

[2]  Z. Ye,et al.  saRNA guided iNOS up-regulation improves erectile function of diabetic rats. , 2013, The Journal of urology.

[3]  C. Vlachopoulos,et al.  Erectile dysfunction in the cardiovascular patient. , 2013, European heart journal.

[4]  M. H. Borges,et al.  New insights on arthropod toxins that potentiate erectile function. , 2013, Toxicon : official journal of the International Society on Toxinology.

[5]  F. Montorsi,et al.  Erectile dysfunction as a cardiovascular risk factor in patients with diabetes , 2013, Endocrine.

[6]  M. Srougi,et al.  Phoneutria nigriventer spider toxin Tx2-6 causes priapism and death: a histopathological investigation in mice. , 2012, Toxicon : official journal of the International Society on Toxinology.

[7]  R. Webb,et al.  Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling , 2011, International Journal of Impotence Research.

[8]  K. Andersson.  Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction , 2011, Pharmacological Reviews.

[9]  A. V. Santos,et al.  Functional expression of a recombinant toxin - rPnTx2-6 - active in erectile function in rat. , 2010, Toxicon : official journal of the International Society on Toxinology.

[10]  V. Cardoso,et al.  Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin from Phoneutria nigriventer spider in rat cavernosal tissue. , 2010, The journal of sexual medicine.

[11]  J. Heidelbaugh.  Management of erectile dysfunction. , 2010, American family physician.

[12]  C. Stief,et al.  Anatomy, physiology, and pathophysiology of erectile dysfunction. , 2010, The journal of sexual medicine.

[13]  D. Kouvelas,et al.  PDE5 inhibitors: in vitro and in vivo pharmacological profile. , 2009, Current pharmaceutical design.

[14]  F. Molina,et al.  Structure and activity analysis of two spider toxins that alter sodium channel inactivation kinetics. , 2009, Biochemistry.

[15]  B. Arnould,et al.  Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study. , 2009, The journal of sexual medicine.

[16]  V. Bovbjerg,et al.  Sexual functioning of Latino women seeking outpatient gynecologic care. , 2009, The journal of sexual medicine.

[17]  M. Srougi,et al.  Penile erection induced in vivo by a purified toxin from the Brazilian spider Phoneutria nigriventer , 2008, BJU international.

[18]  D. Hirst,et al.  Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions , 2008, The Journal of pharmacy and pharmacology.

[19]  R. Webb,et al.  Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function. , 2008, Toxicon : official journal of the International Society on Toxinology.

[20]  L. Derogatis,et al.  The epidemiology of sexual dysfunctions. , 2008, The journal of sexual medicine.

[21]  T. Shioya.  A simple technique for isolating healthy heart cells from mouse models. , 2007, The journal of physiological sciences : JPS.

[22]  M. Litwin,et al.  Health-related quality of life in men with erectile dysfunction , 1998, Journal of General Internal Medicine.

[23]  A. Hajrasouliha,et al.  Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. , 2006, European journal of pharmacology.

[24]  A. Burnett,et al.  RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. , 2006, Clinical science.

[25]  T. Lue,et al.  Physiology of penile erection and pathophysiology of erectile dysfunction. , 2005, The Urologic clinics of North America.

[26]  N. Toda,et al.  Nitric oxide and penile erectile function. , 2005, Pharmacology & therapeutics.

[27]  A. Jungwirth.  [Physiology and pathophysiology of erectile dysfunction]. , 2000, Wiener medizinische Wochenschrift.

[28]  Aytaç,et al.  The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences , 1999, BJU international.

[29]  S. Kaul,et al.  Writing Group Members , 2022 .

[30]  S. Kaul,et al.  ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. , 1999, Journal of the American College of Cardiology.

[31]  J. Tytgat,et al.  Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs , 1992, Neuron.